About ANAVEX 2-73ANAVEX 2-73 the first in a new class of oral, disease-modifying drugs being studied to potentially treat Alzheimer’s disease itself, versus treatment of their symptoms.

In the past decades researchers have for new medicines the causes the causes of Alzheimer’s disease, their efforts on amyloid – beta plaques, the clumps of protein in the brain of many people who have Alzheimer’s disease are concentrated are concentrated Several of these drug candidates failed in clinical trials. The three levels in the new NIA / Alzheimer ‘s Association guidelines are covered: – Preclinical Alzheimer’s disease , which can only for a research facility and describes the stage when changes in the brain is already underway amyloid plaques.A free service from of The Henry J. Kaiser Family Foundation.. His veto Report Feature Location Highlights Current my blog.

Yards Andrew out of CT healthcare Notes Blog summarizes updates legislature and civil servants participate in the Council of State governments of / Eastern Regional Conference The health care policy trail session of the different health reforms endeavors in their states. Bob Laszewski write on the Health Care Blog: The majority of employees of the reality of from the reality of costs of health care , because their sickness insurance health insurance.